Primary Cutaneous Follicle Center Lymphoma Masquerading as Tumid Lupus Erythematosus

Authors

  • Krittin Sowphitakwattana Division of Dermatology, Department of Internal Medicine, Phramongkutklao Hospital, Bangkok 10400, Thailand
  • Supapat Laodheerasiri Division of Dermatology, Department of Medicine, Phramongkutklao Hospital, Bangkok 10400, Thailand

Keywords:

Primary cutaneous follicle center lymphoma (PCFCL), Tumid lupus erythematosus

Abstract

Cutaneous lymphomas, notably indolent cutaneous B-cell lymphoma, can exhibit clinicopathological characteristics resembling those of inflammatory skin conditions. Here, we present the case of an 82-year-old female with recurrent lesions resembling tumid lupus erythematosus on her face. Subsequent histopathological examination and immunohistochemical analysis definitively diagnosed primary cutaneous follicle center lymphoma. This report highlights a rare instance underscoring the importance of considering cutaneous lymphoma as part of the differential diagnosis in patients presenting with inflammatory skin lesions.

References

Dilly M, Ben-Rejeb H, Vergier B, Feldis M, Toty L, Nohra O, et al. Primary cutaneous follicle center lymphoma with Hodgkin and Reed-Sternberglike cells: a new histopathologic variant. J Cutan Pathol. 2014; 41 (10):797-801. https://doi.org/10.1111/cup.12379

J R Goodlad, L Cerroni, S H Swerdlow. Recent advances in cutaneous lymphoma-implications for current and future classifications. Virchows Arch. 2023; 482 (1): 281-98. https://doi.org/10.1007/s00428-022-03421-5

Suárez AL, Pulitzer M, Horwitz S, Moskowitz A, Querfeld C, Myskowski PL. Primary cutaneous B-cell lymphomas: part I. Clinical features, diagnosis, and classification. J Am Acad Dermatol. 2013; 69 (3): 329.e1-13.

Sundram U. Primary Cutaneous B-Cell Lymphomas.Surg Pathol Clin. 2014; 7 (2): 253-83. https://doi.org/10.1016/j.path.2014.02.002

Beaugerie L, Brousse N, Bouvier AM, Colombel JF, Lémann M, Cosnes J, et al. Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study. Lancet. 2009; 374 (9701): 1617-25. https://doi.org/10.1016/S0140-6736(09)61302-7

Koens L, Senff NJ, Vermeer MH, Willemze R, Jansen PM. Methotrexateassociated B-cell lymphoproliferative disorders presenting in the skin: A clinicopathologic and immunophenotypical study of 10 cases. Am J Surg Pathol. 2014; 38 (7): 999-1006. https://doi.org/10.1097/PAS.0000000000000225

Turesson C, Matteson EL.Malignancy as a comorbidity in rheumatic diseases Rheumatology (Oxford). 2013; 52 (1): 5-14. https://doi.org/10.1093/rheumatology/kes189

King JK, Costenbader KH.Characteristics of patients with systemic lupus erythematosus (SLE) and non- Hodgkin's lymphoma (NHL). Clin Rheumatol. 2007; 26 (9): 1491-4. https://doi.org/10.1007/s10067-006-0532-7

Wilcox RA. Cutaneous B-cell lymphomas: 2015 update on diagnosis, risk-stratification, and management. Am J Hematol. 2015; 90 (1): 73-6. https://doi.org/10.1002/ajh.23863

Suárez AL, Pulitzer M, Horwitz S, Moskowitz A, Querfeld C, Myskowski PL. Primary cutaneous B-cell lymphomas: part II. Therapy and future directions. J Am Acad Dermatol. 2013; 69 (3): 343.e1 https://doi.org/10.1016/j.jaad.2013.06.011

Downloads

Published

2024-05-10

How to Cite

Sowphitakwattana, K., & Laodheerasiri, S. . (2024). Primary Cutaneous Follicle Center Lymphoma Masquerading as Tumid Lupus Erythematosus. Greater Mekong Subregion Medical Journal, 4(2), 83–88. Retrieved from https://he02.tci-thaijo.org/index.php/gmsmj/article/view/268028

Issue

Vol. 4 No. 2 (2024): May - August

Section

Short Communication

License

Copyright (c) 2024 Greater Mekong Subregion Medical Journal

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.